Amarin reported $292.78M in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amarin AMRN:US $ 292.78M 0.42M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
AstraZeneca AZN:LN 328M 0M
Epizyme EPZM:US $ 0.01M 0M
Esperion Therapeutics ESPR:US $ 26K 0
GlaxoSmithKline GSK:LN 1347M 1M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 913M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M